acute withdrawal syndrome
Showing 1 - 25 of >10,000
Kratom Product Effects Among Regular Consumers
Not yet recruiting
- Withdrawal Symptoms
- Effects from acute kratom exposure
- (no location specified)
Oct 20, 2023
Weaning From Nasal High Flow Therapy
Completed
- Respiratory Distress Syndrome, Adult
- +3 more
-
Colombes, FranceHôpital Louis Mourier, Assistance Publique - Hôpitaux de Paris
Jan 26, 2022
Opioid Dependence, Acute Opioid Withdrawal Syndrome Trial in United States (Lofexidine HCl, Placebo, Open Label Lofexidine HCL)
Completed
- Opioid Dependence
- Acute Opioid Withdrawal Syndrome
- Lofexidine HCl
- +2 more
-
Clovis, California
- +17 more
Mar 11, 2022
E-cigarette Use, Withdrawal Trial in Baltimore (Transdermal Nicotine Patch, Placebo Nicotine Patch)
Not yet recruiting
- E-cigarette Use
- Withdrawal
- Transdermal Nicotine Patch
- Placebo Nicotine Patch
-
Baltimore, MarylandBehavioral Pharmacology Research Unit
Sep 28, 2023
Neonatal Opioid Withdrawal Syndrome, Neonatal Abstinence Syndrome Trial in Hershey (microRNA-146a level, microRNA-192 level,
Recruiting
- Neonatal Opioid Withdrawal Syndrome
- Neonatal Abstinence Syndrome
- microRNA-146a level
- +2 more
-
Hershey, PennsylvaniaPenn State Milton S. Hershey Medical Center
Jun 30, 2023
Alcohol Withdrawal Delirium, Alcohol Withdrawal, Alcohol Withdrawal Seizures Trial (Phenobarbital Sodium, Inactive )
Unknown status
- Alcohol Withdrawal Delirium
- +2 more
- Phenobarbital Sodium
- Inactive placebo
- (no location specified)
Oct 5, 2020
AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU)
Completed
- Withdrawal Syndrome
- Iatrogenic Disease
-
Wilkes-Barre, PennsylvaniaWilkes University
Jul 28, 2022
Opiate Withdrawal Syndrome, Opioid Use Trial in Philadelphia (LFX/PGB, LFX/PLA-PGB)
Not yet recruiting
- Opiate Withdrawal Syndrome
- Opioid Use
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania, Treatment Research Center
Aug 18, 2023
Glucocorticoid Withdrawal Syndrome in Treated Cushing Syndrome
Recruiting
- Cushing Syndrome
- MUSE biofeedback
-
Rochester, MinnesotaMayo Clinic
Oct 31, 2022
Opioid Withdrawal (Disorder) Trial (Standard of Care with Lofexidine, Standard of Care without Lofexidine)
Not yet recruiting
- Opioid Withdrawal (Disorder)
- Standard of Care with Lofexidine
- Standard of Care without Lofexidine
- (no location specified)
Sep 14, 2023
Opioid Use Disorder, Opioid Withdrawal Trial (BXCL501 (180 micrograms), BXCL501 (240 micrograms), Placebo)
Not yet recruiting
- Opioid Use Disorder
- Opioid Withdrawal
- BXCL501 (180 micrograms)
- +3 more
- (no location specified)
Jan 24, 2023
Methadone vs. Transdermal Fentanyl for Opioid Withdrawal
Not yet recruiting
- Delirium in the Intensive Care Unit
- Administration of methadone instead of fentanyl patch
-
Kfar Saba, IsraelMeir medical center Kfar Saba
Jan 15, 2023
De Novo Metabolic Syndrome in Liver Transplant Patients After
Completed
- Single Transplant
- 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS
-
Rome, ItalyRoberta Angelico
Mar 29, 2023
Using Clonidine and/or Buprenorphine
Recruiting
- Withdrawal Syndrome
- Clonidine, Buprenorphine
-
Surrey, British Columbia, CanadaSalem Anaesthesia Pain Clinic
May 28, 2023
Acute Respiratory Distress Syndrome Trial in Taipei (MatriPlax)
Not yet recruiting
- Acute Respiratory Distress Syndrome
-
Taipei, TaiwanTaipei Medical University Hospital
Jun 1, 2023
Neonatal Abstinence Syndrome Trial in Charleston (Spark Biomedical Roo Transcutaneous Auricular Neurostimulation (tAN) System)
Completed
- Neonatal Abstinence Syndrome
- Spark Biomedical Roo Transcutaneous Auricular Neurostimulation (tAN) System
-
Charleston, South CarolinaMedical University of South Carolina
Dec 7, 2022
Nicotine Dependence Trial in Baltimore (Transcranial Direct Current Stimulation, Sham)
Suspended
- Nicotine Dependence
- Transcranial Direct Current Stimulation
- sham
-
Baltimore, MarylandNational Institute on Drug Abuse
Jan 4, 2023
Neonatal Opiate Withdrawal Syndrome Trial in United States (Symptom-based Dosing Approach, Scheduled Opioid Taper Approach)
Not yet recruiting
- Neonatal Opiate Withdrawal Syndrome
- Symptom-based Dosing Approach
- Scheduled Opioid Taper Approach
-
Birmingham, Alabama
- +8 more
Jul 27, 2023
Opioid Use Disorder, Opioid Withdrawal, Opioid Craving Trial in Baltimore (Buspirone, Lofexidine, Placebo)
Not yet recruiting
- Opioid Use Disorder
- +3 more
- Buspirone
- +2 more
-
Baltimore, MarylandBehavioral Pharmacology Research Unit
Aug 19, 2022
Pattern of Consumption and Withdrawal Syndrome From Dual
Not yet recruiting
- Cannabis Dependence
- +3 more
- (no location specified)
Aug 20, 2022
Alcohol Withdrawal Syndrome With Alpha-2 Agonists and/or
Completed
- Alcohol Withdrawal Syndrome
- BZDP-Sparing Protocol
- BZDP-Based Protocol
-
Stanford, CaliforniaStanford Hospital and Clinics
Jun 24, 2022
Drug Withdrawal Symptoms, Critical Care, Child Trial in Oslo (Algorithm for tapering og analgosedation)
Completed
- Drug Withdrawal Symptoms
- +2 more
- Algorithm for tapering og analgosedation
-
Oslo, NorwayOslo University Hospital, Rikshospitalet
Apr 19, 2022
Iatrogenic Withdrawal Syndrome Trial in Nashville (Acupressure)
Recruiting
- Iatrogenic Withdrawal Syndrome
- Acupressure
-
Nashville, TennesseeVanderbilt University Medical Center
Jun 5, 2022
Opiate Withdrawal Syndrome Trial in Zagazig (Venlafaxine, Lofexidine)
Completed
- Opiate Withdrawal Syndrome
-
Zagazig, Sharkia, EgyptFaculty of medicine
Oct 5, 2022